The risks aren't
In their family-based study, relatives of people with BP-II had a higher risk of also having BP-II, suggesting it tends to run specifically in families (Heun and Maier, 1993)
Simpson regards these treatments as reasonable things we can do to [increase] our health span and life span. Jeremie Walker, M.D., Dr
Side Effect Severity Framework: What Clinical Evidence Shows Clinical trials and real-world data reveal that tirzepatide side effects follow a severity spectrum
Patients often ask about it because of its association with tissue support, recovery-focused care, and wellness goals
The most significant aflatoxins in terms of toxicity and prevalence are Aflatoxin B1 (AFB1), B2 (AFB2), G1 (AFG1), G2 (AFG2), and M1 (AFM1) as shown in Table 1